Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 609579, 12 pages
http://dx.doi.org/10.1155/2011/609579
Review Article

Toll-Like Receptor 4 Activation in Cancer Progression and Therapy

Alja Oblak1,2 and Roman Jerala1,2,3

1Department of Biotechnology, National Institute of Chemistry, 1000 Ljubljana, Slovenia
2EN-FIST Centre of Excellence, 1000 Ljubljana, Slovenia
3Faculty of Chemistry and Chemical Technology, University of Ljubljana, 1000 Ljubljana, Slovenia

Received 1 July 2011; Accepted 1 September 2011

Academic Editor: David Kaplan

Copyright © 2011 Alja Oblak and Roman Jerala. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [81 citations]

The following is the list of published articles that have cited the current article.

  • Soudeh Ghafouri-Fard, and Somayyeh Ghafouri-Fard, “siRNA and cancer immunotherapy,” Immunotherapy, vol. 4, no. 9, pp. 907–917, 2012. View at Publisher · View at Google Scholar
  • Ting Jia, Haiying Fu, Jitong Sun, Yinglin Zhang, Wei Yang, and Yi Li, “Foxp3 expression in A549 cells is regulated by Toll-like receptor 4 through nuclear factor-kappa B,” Molecular Medicine Reports, vol. 6, no. 1, pp. 167–172, 2012. View at Publisher · View at Google Scholar
  • Erika Vacchelli, Isabelle Martins, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer, and Lorenzo Galluzzi, “Trial watch: Peptide vaccines in cancer therapy,” OncoImmunology, vol. 1, no. 9, pp. 1557–1576, 2012. View at Publisher · View at Google Scholar
  • Mi Hyeon Cho, Eun Jung Lee, Mina Son, Jae-Hyun Lee, Dongwon Yoo, Ji-wook Kim, Seung Woo Park, Jeon-Soo Shin, and Jinwoo Cheon, “A magnetic switch for the control of cell death signalling in in vitro and in vivo systems,” Nature Materials, 2012. View at Publisher · View at Google Scholar
  • C. Maletzki, U. Klier, W. Obst, B. Kreikemeyer, and M. Linnebacher, “Reevaluating the Concept of Treating Experimental Tumors with a Mixed Bacterial Vaccine: Coley’s Toxin,” Clinical and Developmental Immunology, vol. 2012, pp. 1–16, 2012. View at Publisher · View at Google Scholar
  • Gabriele Multhoff, and Jürgen Radons, “Radiation, inflammation, and immune responses in cancer.,” Frontiers in oncology, vol. 2, pp. 58, 2012. View at Publisher · View at Google Scholar
  • Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer, and Lorenzo Galluzzi, “Trial Watch: Toll-like receptor agonists for cancer therapy,” OncoImmunology, vol. 2, no. 8, pp. e25238, 2013. View at Publisher · View at Google Scholar
  • Jens Bedke, and Arnulf Stenzl, “IMA901: a peptide vaccine in renal cell carcinoma,” Expert Opinion on Investigational Drugs, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  • K. M. Applebaum, R. M. Ray, G. Astrakianakis, D. L. Gao, D. B. Thomas, D. C. Christiani, M. P. LaValley, W. Li, H. Checkoway, and E. A. Eisen, “Evidence of a paradoxical relationship between endotoxin and lung cancer after accounting for left truncation in a study of Chinese female textile workers,” Occupational and Environmental Medicine, 2013. View at Publisher · View at Google Scholar
  • T Yamazaki, D Hannani, V Poirier-Colame, S Ladoire, C Locher, A Sistigu, N Prada, S Adjemian, J Pp Catani, M Freudenberg, C Galanos, F André, G Kroemer, and L Zitvogel, “Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists,” Cell Death and Differentiation, 2013. View at Publisher · View at Google Scholar
  • Laura Senovilla, Erika Vacchelli, Pauline Garcia, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer, and Lorenzo Galluzzi, “Trial watch: DNA vaccines for cancer therapy,” OncoImmunology, vol. 2, no. 4, pp. e23803, 2013. View at Publisher · View at Google Scholar
  • Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jerome Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer, and Lorenzo Galluzzi, “Trial Watch: Peptide vaccines in cancer therapy,” OncoImmunology, vol. 2, no. 12, pp. e26621, 2013. View at Publisher · View at Google Scholar
  • Zhi-Feng Wu, Xiao-Hui Zhou, Yun-Wen Hu, Le-Yuan Zhou, Ya-Bo Gao, Xiu-Hua Peng, Xiao-Hua Yang, Jian-Ying Zhang, Yong Hu, and Zhao-Chong Zeng, “TLR4-dependant immune response, but not hepatitis B virus reactivation, is important in radiation-induced liver disease of liver cancer radiotherapy,” Cancer Immunology, Immunotherapy, vol. 63, no. 3, pp. 235–245, 2013. View at Publisher · View at Google Scholar
  • Naureen Ehsan, Sheeba Murad, Tamour Ashiq, Muhammad Uzair Mansoor, Summer Gul, Samra Khalid, and Muhammad Younas, “Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast,” Tumor Biology, vol. 34, no. 2, pp. 1053–1059, 2013. View at Publisher · View at Google Scholar
  • J H Kauppila, A E Mattila, T J Karttunen, and T Salo, “Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue,” British Journal of Cancer, vol. 108, no. 3, pp. 638–643, 2013. View at Publisher · View at Google Scholar
  • William S. Bowen, Siva K. Gandhapudi, Joseph P. Kolb, and Thomas C. Mitchell, “Immunopharmacology of Lipid A Mimetics,” Immunopharmacology, vol. 66, pp. 81–128, 2013. View at Publisher · View at Google Scholar
  • Chun Wai Mai, Yew Beng Kang, and Mallikarjuna Rao Pichika, “Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers,” Oncotargets and Therapy, vol. 6, pp. 1573–1587, 2013. View at Publisher · View at Google Scholar
  • Tej K. Pandita, Clayton R. Hunt, Xuchen Zhang, Peiying Shan, Patty J. Lee, and Yi Zhang, “A Protective Hsp70-TLR4 Pathway in Lethal Oxidant Lung Injury,” Journal Of Immunology, vol. 191, no. 3, pp. 1393–1403, 2013. View at Publisher · View at Google Scholar
  • Hongying Duan, Like Qu, and Chengchao Shou, “Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-κB signaling,” Cancer Letters, 2014. View at Publisher · View at Google Scholar
  • Jian Li, Zong-Gang Xie, Ye Xie, and Qi-Rong Dong, “Calcitonin treatment is associated with less severe osteoarthritis and reduced toll-like receptor levels in a rat model,” Journal of Orthopaedic Science, 2014. View at Publisher · View at Google Scholar
  • Meng Gao, Nir London, Kui Cheng, Ryo Tamura, Jialin Jin, Ora Schueler-Furman, and Hang Yin, “Rationally designed macrocyclic peptides as synergistic agonists of LPS-induced inflammatory response,” Tetrahedron, 2014. View at Publisher · View at Google Scholar
  • Shanjana Awasthi, “Toll-Like Receptor-4 Modulation for Cancer Immunotherapy,” Frontiers in Immunology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Steffen Rausch, Stephan Kruck, Arnulf Stenzl, and Jens Bedke, “IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy,” Future Oncology, vol. 10, no. 6, pp. 937–948, 2014. View at Publisher · View at Google Scholar
  • Daye Cheng, Yiwen Hao, Wenling Zhou, and Yiran Ma, “Association between Toll-like receptor 3 polymorphisms and cancer risk: a meta-analysis,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Madhuwanti Srinivasan, Souresh Banerjee, Allison Palmer, Guoxing Zheng, Aoshuang Chen, Maarten C. Bosland, André Kajdacsy-Balla, Ramaswamy Kalyanasundaram, and Gnanasekar Munirathinam, “HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target,” Hormones and Cancer, 2014. View at Publisher · View at Google Scholar
  • Afshin Beheshti, Michael Peluso, Clare Lamont, Philip Hahnfeldt, and Lynn Hlatky, “Proton Irradiation Augments the Suppression of Tumor Progression Observed with Advanced Age,” Radiation Research, vol. 181, no. 3, pp. 272–283, 2014. View at Publisher · View at Google Scholar
  • Teresa Trotta, Chiara Porro, Rosa Calvello, and Maria Antonietta Panaro, “Biological role of Toll-Like Receptor-4 in the brain,” Journal of Neuroimmunology, 2014. View at Publisher · View at Google Scholar
  • Wu Zhi-Feng, Zhou Le-Yuan, Zhou Xiao-Hui, Gao Ya-Bo, Zhang Jian-Ying, Hu Yong, and Zeng Zhao-Chong, “TLR4-Dependent Immune Response Promotes Radiation-Induced Liver Disease by Changing the Liver Tissue Interstitial Microenvironment during Liver Cancer Radiotherapy,” Radiation Research, vol. 182, no. 6, pp. 674–682, 2014. View at Publisher · View at Google Scholar
  • Zhifeng He, Runzhi Deng, Xiaofeng Huang, Yanhong Ni, Xudong Yang, Zhiyong Wang, and Qingang Hu, “Lipopolysaccharide enhances OSCC migration by promoting epithelial-mesenchymal transition,” Journal of Oral Pathology & Medicine, 2014. View at Publisher · View at Google Scholar
  • Joonas H. Kauppila, Johanna Korvala, Kristiina Siirilä, Marika Manni, Laura K. Mäkinen, Jaana Hagström, Timo Atula, Caj Haglund, Katri S. Selander, Juha Saarnio, Tuomo J. Karttunen, Petri P. Lehenkari, and Tuula Salo, “Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue,” Journal of Oral Pathology & Medicine, 2014. View at Publisher · View at Google Scholar
  • Guanghua Li, Zhao Wang, Jinning Ye, Xinhua Zhang, Hui Wu, Jianjun Peng, Wu Song, Chuangqi Chen, Shirong Cai, Yulong He, and Jianbo Xu, “Uncontrolled Inflammation Induced by AEG-1 Promotes Gastric Cancer and Poor Prognosis,” Cancer Research, vol. 74, no. 19, pp. 5541–5552, 2014. View at Publisher · View at Google Scholar
  • Antonio Molinaro, Otto Holst, Flaviana Di Lorenzo, Maire Callaghan, Alessandra Nurisso, Gerardino D'Errico, Alla Zamyatina, Francesco Peri, Rita Berisio, Roman Jerala, Jesús Jiménez-Barbero, Alba Silipo, and Sonsoles Martín-Santamaría, “Chemistry of Lipid A: At the Heart of Innate Immunity,” Chemistry - A European Journal, 2014. View at Publisher · View at Google Scholar
  • Ines Omrane, Olfa Baroudi, Nadia Kourda, Yves-Jean Bignon, Nancy Uhrhammer, Alexis Desrichard, Imen Medimegh, Hager Ayari, Nejla Stambouli, Amel Mezlini, Hssan Bouzayenne, Raja Marrakchi, Amel Benammar-Elgaaid, and Karim Bougatef, “Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis,” Tumor Biology, vol. 35, no. 1, pp. 545–551, 2014. View at Publisher · View at Google Scholar
  • C R Balistreri, G Candore, D Lio, and G Carruba, “Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments,” Cancer Gene Therapy, vol. 21, no. 1, pp. 2–11, 2014. View at Publisher · View at Google Scholar
  • Ahmed A. Al-Qahtani, Mashael R. Al-Anazi, Fahad Al-Zoghaibi, Ayman A. Abdo, Faisal M. Sanai, Mohammed Q. Khan, Ali Albenmousa, Hamad I. Al-Ashgar, and Mohammed N. Al-Ahdal, “The Association of Toll-Like Receptor 4 Polymorphism with Hepatitis C Virus Infection in Saudi Arabian Patients,” BioMed Research International, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Aiqin He, Rui Ji, Jia Shao, Chenyun He, Ming Jin, and Yunzhao Xu, “TLR4-MyD88-TRAF6-TAK1 Complex-Mediated NF-κB Activation Contribute to the Anti-Inflammatory Effect of V8 in LPS-Induced Human Cervical Cancer SiHa Cells,” Inflammation, 2015. View at Publisher · View at Google Scholar
  • Janis Liepins, Elena Kovacova, Karlis Shvirksts, Mara Grube, Alexander Rapoport, and Grigorij Kogan, “Drying enhances immunoactivity of spent brewer's yeast cell wall beta-D-glucans,” Journal Of Biotechnology, vol. 206, pp. 12–16, 2015. View at Publisher · View at Google Scholar
  • Jing Xue, “Tlr4,” Encyclopedia of Cancer, pp. 1–3, 2015. View at Publisher · View at Google Scholar
  • Sophia Ran, “The Role of TLR4 in Chemotherapy-Driven Metastasis,” Cancer Research, vol. 75, no. 12, pp. 2405–2410, 2015. View at Publisher · View at Google Scholar
  • S. G. Daniele, D. Beraud, C. Davenport, K. Cheng, H. Yin, and K. A. Maguire-Zeiss, “Activation of MyD88-dependent TLR1/2 signaling by misfolded  -synuclein, a protein linked to neurodegenerative disorders,” Science Signaling, vol. 8, no. 376, pp. ra45–ra45, 2015. View at Publisher · View at Google Scholar
  • Sumeet Jain, Sujit Suklabaidya, Biswajit Das, Sunil K. Raghav, Surinder K. Batra, and Shantibhusan Senapati, “TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Kuppusamy Balamurugan, “HIF-1 at the crossroads of hypoxia, inflammation, and cancer,” International Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Sabah Ahmed, Marwa Moawad, Radwa Elhefny, and Mona Abdullatif, “Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis?,” Egyptian Journal of Chest Diseases and Tuberculosis, 2015. View at Publisher · View at Google Scholar
  • Pini Matzner, Liat Sorski, Lee Shaashua, Ely Elbaz, Hagar Lavon, Rivka Melamed, Ella Rosenne, Neta Gotlieb, Amit Benbenishty, Steve G. Reed, and Shamgar Ben-Eliyahu, “Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects,” International Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Julie A. Alosi, Scott W. Baldwin, Jacqueline Oxenberg, and Joseph J. Skitzkipp. 319–332, 2015. View at Publisher · View at Google Scholar
  • Shanjana Awasthi, Asokan Anbanandam, and Karla K. Rodgers, “Structure of a TLR4-interacting SPA4 peptide,” RSC Adv., vol. 5, no. 35, pp. 27431–27438, 2015. View at Publisher · View at Google Scholar
  • Wang Yan Sheng, Zhang Yong, Zhu Yun, Hu Hong, and Luo Lin Hai, “Toll-like receptor 4 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review,” Archives Of Medical Science, vol. 11, no. 4, pp. 699–707, 2015. View at Publisher · View at Google Scholar
  • Feng Liu, Jun Liu, Bei Wen, and Jintao Du, “Identification of key target genes and pathways in laryngeal carcinoma,” Oncology Letters, vol. 12, no. 2, pp. 1279–1286, 2016. View at Publisher · View at Google Scholar
  • Haichong Wu, Gan Zhao, Kangfeng Jiang, Chengye Li, Changwei Qiu, and Ganzhen Deng, “Engeletin alleviates lipopolysaccharide-induced endometritis in mice by inhibiting TLR4-mediated NF-κB activation,” Journal of Agricultural and Food Chemistry, 2016. View at Publisher · View at Google Scholar
  • Chao Xie, Danqing Liu, Qijun Chen, Chong Yang, Bo Wang, and Heshui Wu, “Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway,” Scientific Reports, vol. 6, pp. 27528, 2016. View at Publisher · View at Google Scholar
  • Kai Ye, Yiyang Wu, Yafeng Sun, Jian'an Lin, and Jianhua Xu, “TLR4 siRNA inhibits proliferation and invasion in colorectal cancer cells by downregulating ACAT1 expression,” Life Sciences, 2016. View at Publisher · View at Google Scholar
  • Jinju Yang, Nannan Qin, Hongwei Zhang, Rui Yang, Benqiong Xiang, and Qun Wei, “Cellular uptake of exogenous calcineurin B is dependent on TLR4/MD2/CD14 complexes, and CnB is an endogenous ligand of TLR4,” Scientific Reports, vol. 6, pp. 24346, 2016. View at Publisher · View at Google Scholar
  • Yuji Nadatani, Xiaofang Huo, Xi Zhang, Chunhua Yu, Edaire Cheng, Qiuyang Zhang, Kerry B. Dunbar, Arianne Theiss, Thai H. Pham, David H. Wang, Toshio Watanabe, Yasuhiro Fujiwara, Tetsuo Arakawa, Stuart J. Spechler, and Rhonda F. Souza, “NOD-Like Receptor Protein 3 (NLRP3) Inflammasome Priming and Activation in Barrett’s Epithelial Cells,” CMGH Cellular and Molecular Gastroenterology and Hepatology, 2016. View at Publisher · View at Google Scholar
  • Franco Pandolfi, Simona Altamura, Simona Frosali, and Pio Conti, “Key Role of DAMP in Inflammation, Cancer, and Tissue Repair,” Clinical Therapeutics, 2016. View at Publisher · View at Google Scholar
  • Junichi Sakamoto, Michitaka Honda, and Toru Aoyamapp. 21–35, 2016. View at Publisher · View at Google Scholar
  • H.N. Lynch, C.T. Loftus, J.M. Cohen, L.E. Kerper, E.M. Kennedy, and J.E. Goodman, “Weight-of-evidence evaluation of associations between particulate matter exposure and biomarkers of lung cancer,” Regulatory Toxicology and Pharmacology, 2016. View at Publisher · View at Google Scholar
  • Kawther K. Ahmed, Sean M. Geary, and Aliasger K. Salem, “Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine,” Journal of Pharmaceutical Sciences, 2016. View at Publisher · View at Google Scholar
  • Rodolfo Montironi, Matteo Santoni, Valeria Sotte, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Marc R. Matrana, Holger Moch, Rossana Berardi, and Marina Scarpelli, “Emerging Immunotargets and Immunotherapies in Prostate Cancer,” Current Drug Targets, vol. 17, no. 7, pp. 777–782, 2016. View at Publisher · View at Google Scholar
  • Monika Cervinkova, Petra Kucerova, and Jana Cizkova, “Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens?,” Anti-Cancer Drugs, vol. 28, no. 8, pp. 819–830, 2017. View at Publisher · View at Google Scholar
  • Kai Ye, Qi-Wei Chen, Ya-Feng Sun, Jian-An Lin, and Jian-Hua Xu, “Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling,” Journal of Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar
  • Jing Xue, “Tlr4,” Encyclopedia of Cancer, pp. 4561–4563, 2017. View at Publisher · View at Google Scholar
  • Javier Egea, Isabel Fabregat, Yves M. Frapart, Pietro Ghezzi, Agnes Görlach, Thomas Kietzmann, Kateryna Kubaichuk, Ulla G. Knaus, Manuela G. Lopez, Gloria Olaso-Gonzalez, Andreas Petry, Rainer Schulz, Jose Vina, Paul Winyard, Kahina Abbas, Stella Ademowo, Catarina B. Afonso, Ioanna Andreadou, Haike Antelmann, Fernando Antunes, Mutay Aslan, Markus M. Bachschmid, Rui M. Barbosa, Vsevolod Belousov, Carsten Berndt, David Bernlohr, Esther Bertrán, Alberto Bindoli, Serge P. Bottari, Paula M. Brito, Guia Carrara, Ana I. Casas, Afroditi Chatzi, Niki Chondrogianni, Marcus Conrad, Marcus S. Cooke, João G. Costa, Antonio Cuadrado, Pham My-Chan Dang, Barbara De Smet, Bilge Debelec–Butuner, Irundika Dias, Joe Dan Dunn, Amanda J. Edson, Mariam El Assar, Jamel El-Benna, Péter Ferdinandy, Ana S. Fernandes, Kari E. Fladmark, Ulrich Förstermann, Rashid Giniatullin, Zoltán Giricz, Anikó Görbe, Helen Griffiths, Vaclav Hampl, Alina Hanf, Jan Herget, Pablo Hernansanz-Agustín, Melanie Hillion, Jinjing Huang, Serap Ilikay, Pidder Jansen-Dürr, Vincent Jaquet, Jaap A. Joles, Balaraman Kalyanaraman, Danylo Kaminskyy, Mahsa Karbaschi, Marina Kleanthous, Lars-Oliver Klotz, Bato Korac, Kemal Sami Korkmaz, Rafal Koziel, Damir Kračun, Karl-Heinz Krause, Vladimír Křen, Thomas Krieg, João Laranjinha, Antigone Lazou, Huige Li, Antonio Martínez-Ruiz, Reiko Matsui, Gethin J. McBean, Stuart P. Meredith, Joris Messens, Verónica Miguel, Yuliya Mikhed, Irina Milisav, Lidija Milković, Antonio Miranda-Vizuete, Milos Mojović, María Monsalve, Pierre-Alexis Mouthuy, John Mulvey, Thomas Münzel, Vladimir Muzykantov, Isabel T.N. Nguyen, Matthias Oelze, Nuno G. Oliveira, Carlos M. Palmeira, Nikoletta Papaevgeniou, Aleksandra Pavićević, Brandán Pedre, Fabienne Peyrot, Marios Phylactides, Gratiela G. Pircalabioru, Andrew R. Pitt, Henrik E. Poulsen, Ignacio Prieto, Maria Pia Rigobello, Natalia Robledinos-Antón, Leocadio Rodríguez-Mañas, Anabela P. Rolo, Francis Rousset, Tatjana Ruskovska, Nuno Saraiva, Shlomo Sasson, Katrin Schröder, Khrystyna Semen, Tamara Seredenina, Anastasia Shakirzyanova, Geoffrey L. Smith, Thierry Soldati, Bebiana C. Sousa, Corinne M. Spickett, Ana Stancic, Marie José Stasia, Holger Steinbrenner, Višnja Stepanić, Sebastian Steven, Kostas Tokatlidis, Erkan Tuncay, Belma Turan, Fulvio Ursini, Jan Vacek, Olga Vajnerova, Kateřina Valentová, Frank Van Breusegem, Lokman Varisli, Elizabeth A. Veal, A. Suha Yalçın, Olha Yelisyeyeva, Neven Žarković, Martina Zatloukalová, Jacek Zielonka, Rhian M. Touyz, Andreas Papapetropoulos, Tilman Grune, Santiago Lamas, Harald H.H.W. Schmidt, Fabio Di Lisa, and Andreas Daiber, “European Contribution to the study of ROS: A Summary of the Findings and Prospects for the Future from the COST Action BM1203 (EU-ROS),” Redox Biology, 2017. View at Publisher · View at Google Scholar
  • Ala’a Al-Bakheit, Saeid Abu-Romman, Ahmad Sharab, and Mohammad Al Shhab, “ Anti-inflammatory effect of Varthemia iphionoides extracts against prostate cancer in vitro ,” European Journal of Inflammation, pp. 1721727X1770215, 2017. View at Publisher · View at Google Scholar
  • C-H Wang, P-J Wang, Y-C Hsieh, S Lo, Y-C Lee, Y-C Chen, C-H Tsai, W-C Chiu, S Chu-Sung Hu, C-W Lu, Y-F Yang, C-C Chiu, F Ou-Yang, Y-M Wang, M-F Hou, and S-Sf Yuan, “Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties,” Oncogene, 2017. View at Publisher · View at Google Scholar
  • Mihiri Mendis, Estelle Leclerc, and Senay Simsek, “Arabinoxylan hydrolyzates as immunomodulators in Caco-2 and HT-29 colon cancer cell lines,” Food Funct., 2017. View at Publisher · View at Google Scholar
  • Karthik Vasan, Suzane Ramos Da Silva, Shou-Jiang Gao, Marion Gruffaz, and Brandon Tan, “TLR4-mediated inflammation promotes KSHV-induced cellular transformation and tumorigenesis by activating the STAT3 pathway,” Cancer Research, vol. 77, no. 24, pp. 7094–7108, 2017. View at Publisher · View at Google Scholar
  • Javanmard, Dana, and Vaseghi, “Effect of lipopolysaccharide on toll-like receptor-4 signals in mouse cancer cells,” Bratislava Medical Journal, vol. 118, no. 10, pp. 598–601, 2017. View at Publisher · View at Google Scholar
  • Maryam A. Shetab Boushehri, and Alf Lamprecht, “TLR4-based immunotherapeutics in cancer: a review of the achievements and shortcomings,” Molecular Pharmaceutics, 2018. View at Publisher · View at Google Scholar
  • Jayne Marasa, David Piwnica-Worms, Kelly Flentie, Caleb Gonzalez, Brandon Kocher, Yue Wang, and Hongtu Zhu, “Nucleoside diphosphate kinase-3 (NME3) enhances TLR5-induced NFkB activation,” Molecular Cancer Research, vol. 16, no. 6, pp. 986–999, 2018. View at Publisher · View at Google Scholar
  • Vinita Mishra, and Chandramani Pathak, “ Structural insights into pharmacophore-assisted in silico identification of protein–protein interaction inhibitors for inhibition of human toll-like receptor 4 – myeloid differentiation factor-2 (hTLR4−MD-2) complex ,” Journal of Biomolecular Structure and Dynamics, pp. 1–24, 2018. View at Publisher · View at Google Scholar
  • Gan Tao Chen, Yan Qing Wang, Shu Xian, Yan Xiang Cheng, Xiao Yang, Li Zhang, Shao Ming Zhu, and Feng Pan, “TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention,” Molecular Medicine Reports, vol. 17, no. 2, pp. 2229–2238, 2018. View at Publisher · View at Google Scholar
  • Vinita Mishra, and Chandramani Pathak, “Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer,” International Journal of Biological Macromolecules, 2018. View at Publisher · View at Google Scholar
  • Nilesh Pandey, Alex Chauhan, and Neeraj Jain, “TLR4 Polymorphisms and Expression in Solid Cancers,” Molecular Diagnosis & Therapy, 2018. View at Publisher · View at Google Scholar
  • Luiz Gustavo de Almeida Chuffa, Grazielle de Moura Ferreira, Luiz Antonio Lupi, Iseu da Silva Nunes, and Wagner José Fávaro, “P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling,” Journal of Ovarian Research, vol. 11, no. 1, 2018. View at Publisher · View at Google Scholar
  • Mateja Manček-Keber, Duško Lainšček, Mojca Benčina, Jiaji G. Chen, Rok Romih, Zachary R. Hunter, Steven P. Treon, and Roman Jerala, “ Extracellular vesicle–mediated transfer of constitutively active MyD88 L265P engages MyD88 wt and activates signaling ,” Blood, vol. 131, no. 15, pp. 1720–1729, 2018. View at Publisher · View at Google Scholar
  • Rong-Rong Yao, Jing-Huan Li, Rui Zhang, Rong-Xin Chen, and Yan-Hong Wang, “M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway,” World Journal of Surgical Oncology, vol. 16, no. 1, 2018. View at Publisher · View at Google Scholar
  • Nilesh O. Pandey, Alex V. Chauhan, Nitin S. Raithatha, Purvi K. Patel, Ronak Khandelwal, Ajesh N. Desai, Yesha Choxi, Rutul S. Kapadia, and Neeraj D. Jain, “Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar
  • Rossana Domenis, Adriana Cifù, Daniele Marinò, Martina Fabris, Kayvan R. Niazi, Patrick Soon-Shiong, and Francesco Curcio, “Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar
  • Jinju Yang, Hongwei Zhang, Ziwei Zhu, Yadan Gao, Benqiong Xiang, and Qun Wei, “The immunostimulatory effects and pro-apoptotic activity of rhCNB against Lewis lung cancer is mediated by Toll-like receptor 4,” Cancer Medicine, 2019. View at Publisher · View at Google Scholar
  • Shirin Mahmoodi, and Navid Nezafat, “ In Silico Designing a Novel Multi-epitope DNA Vaccine against Anti-apoptotic Proteins in Tumor Cells ,” Current Proteomics, vol. 16, no. 3, pp. 222–230, 2019. View at Publisher · View at Google Scholar
  • Nan Li, Huanbai Xu, Yurong Ou, Zhenzhong Feng, Qiong Zhang, Qing Zhu, and Zhaogen Cai, “LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway,” Diagnostic Pathology, vol. 14, no. 1, 2019. View at Publisher · View at Google Scholar